Clinical Trial Update: First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study [Phase 3]

View source ↗

Summary

Phase III randomized study comparing first-line MCapOX plus cetuximab versus MFOLFOX6 plus cetuximab in RAS/BRAF wild-type, MSS, unresectable left-sided metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cetuximab (cetuximab)
• FLUOROURACIL (Fluorouracil)
• Folinic acid (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Meng Qiu | Conditions: Colorectal Cancer (CRC), Capecitabine | Phase 3 | Status: NOT_YET_RECRUITING